The Antidepressant Debate: Emerging Research Challenges Decades of Psychiatric Orthodoxy on July 29, 2026 Posted by
Chronic Cough “Comes of Age”: A Landmark Shift in Respiratory Medicine at the Inaugural ERS Cough Conference on July 29, 2026 Posted by
The Sentinel’s Role: Navigating Bipolar Disorder Through the Lens of Friendship and Early Intervention on July 29, 2026 Posted by
Boston Scientific Faces Strategic Reset: Sales Guidance Slashed Amid Market Headwinds on July 29, 2026 Posted by
The Antidepressant Debate: Emerging Research Challenges Decades of Psychiatric Orthodoxy on July 29, 2026 Posted by
Chronic Cough “Comes of Age”: A Landmark Shift in Respiratory Medicine at the Inaugural ERS Cough Conference on July 29, 2026 Posted by
The Sentinel’s Role: Navigating Bipolar Disorder Through the Lens of Friendship and Early Intervention on July 29, 2026 Posted by
Posted in Sleep Health Beyond the Hose: A Comprehensive Guide to Expiratory Positive Airway Pressure (EPAP) Therapy on July 24, 2026
Posted in Medical Innovations New Hope for Advanced Lung Cancer: FDA Approves Zidesamtinib for Pre-Treated ROS1-Positive NSCLC on July 23, 2026
Posted in Respiratory Health Precision Oncology Milestone: GSK’s Jideytro (Zidesamtinib) Receives Landmark FDA Approval for ROS1-Positive NSCLC on July 22, 2026
Posted in Sleep Health Avecho Biotechnology Cleared for Full Enrollment in Pivotal Insomnia Trial Following Positive Interim CBD Analysis on July 21, 2026
Posted in Sleep Health Beyond the Mask: A Comprehensive Guide to Expiratory Positive Airway Pressure (EPAP) Therapy for Sleep Apnea on July 16, 2026
Posted in Caregiver Support Legionnaires’ Outbreak in New York City: Guggenheim Museum Among Dozens Testing Positive for Bacteria on July 12, 2026
Posted in Sleep Health Beyond CPAP: A Comprehensive Guide to Expiratory Positive Airway Pressure (EPAP) Therapy on July 8, 2026
Posted in Medical Innovations Navigating the Silent Threat: The Escalating Challenge of Brain Metastases in HER2-Positive Breast Cancer on June 22, 2026
Posted in Medical Innovations Johnson & Johnson Bolsters Oncology Portfolio with Positive Phase 3 Data for Talvey Combination Therapy on June 16, 2026
Posted in Medical Innovations A New Era in Lung Cancer Care: Selpercatinib Establishes Standard for RET Fusion-Positive NSCLC on May 31, 2026 rifanmuazin
